Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases

Helm, Jacob; Schoels, Ludger; Hauser, Stefan

dc.contributor.author	Helm, Jacob
dc.contributor.author	Hauser, Stefan
dc.contributor.author	Schöls, Ludger
dc.date.accessioned	2023-06-06T06:44:08Z
dc.date.available	2023-06-06T06:44:08Z
dc.date.issued	2022
dc.identifier.issn	1999-4923
dc.identifier.uri	http://hdl.handle.net/10900/141855
dc.language.iso	en	de_DE
dc.publisher	Mdpi	de_DE
dc.relation.uri	http://dx.doi.org/10.3390/pharmaceutics14081708	de_DE
dc.subject.ddc	610	de_DE
dc.title	Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_02015
utue.personen.roh	Helm, Jacob
utue.personen.roh	Schoels, Ludger
utue.personen.roh	Hauser, Stefan
dcterms.isPartOf.ZSTitelID	Pharmaceutics	de_DE
dcterms.isPartOf.ZS-Issue	Article 1708	de_DE
dcterms.isPartOf.ZS-Volume	14 (8)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE